Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Days Payable Chart
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Annual Data
Trend
Dec21
Dec22
Dec23
Dec24
Dec25
Days Payable
67.97
83.80
58.52
44.73
53.88
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Semi-Annual Data
HKSE:02566 vs VRTX, REGN, RVMD: Days Payable Comparison
For the Biotechnology subindustry, Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Days Payable vs Biotechnology Industry
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Jiuyuan Genetic Biopharmaceutical Co (HKSE:02566) has a Days Payable of 54.87 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hangzhou Jiuyuan Genetic Biopharmaceutical Co and its competitors. This is near median its historical median of 58.52. Over the past decade, Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Days Payable has ranged from 44.73 to 83.80. According to the industry distribution chart, Hangzhou Jiuyuan Genetic Biopharmaceutical Co ranks #461 out of 703 companies in the Biotechnology industry, placing it in the top 65.6%.
Is Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Days Payable too high?
Hangzhou Jiuyuan Genetic Biopharmaceutical Co's current Days Payable of 54.87 is near median its 10-year median of 58.52. Over the past 10 years, this metric has ranged from a low of 44.73 to a high of 83.80. The Biotechnology industry median Days Payable is 112.39. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's value of 54.87 is 51.2% below this industry median. Based on the distribution chart, Hangzhou Jiuyuan Genetic Biopharmaceutical Co ranks #461 out of 703 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Hangzhou Jiuyuan Genetic Biopharmaceutical Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Hangzhou Jiuyuan Genetic Biopharmaceutical Co ranks #461 out of 703 companies for Days Payable. This places Hangzhou Jiuyuan Genetic Biopharmaceutical Co in the lower half of its industry. The industry median Days Payable is 112.39. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's value of 54.87 is 51.2% below this benchmark. Historically, Hangzhou Jiuyuan Genetic Biopharmaceutical Co's own Days Payable has ranged from 44.73 to 83.80 over the past decade. While the company's 10-year median is 58.52 vs. the industry median of 112.39, Hangzhou Jiuyuan Genetic Biopharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.39, based on 703 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's current Days Payable of 54.87 is 51.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hangzhou Jiuyuan Genetic Biopharmaceutical Co and its competitors. For the Biotechnology industry, the median Days Payable is 112.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's current Days Payable is 54.87, which is near median its own 10-year median of 58.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Jiuyuan Genetic Biopharmaceutical Co stock overvalued right now?
Hangzhou Jiuyuan Genetic Biopharmaceutical Co (HKSE:02566) has a current Days Payable of 54.87. The current Days Payable is 54.87, which is near median its 10-year median of 58.52 and 51.2% below the Biotechnology industry median of 112.39. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Hangzhou Jiuyuan Genetic Biopharmaceutical Co (HKSE:02566), the current Days Payable is 54.87 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd is a biopharmaceutical company in China. It is engaged in the research & development, manufacturing, and commercialization of biopharmaceutical products and medical devices. The company focuses on four large and fast-growing therapeutic areas: orthopedics, metabolic diseases, oncology, and hematology. Centered around these therapeutic areas, it has built a diversified product portfolio comprising several marketed products, such as Jilifen, Jijufen, Jiouting, Yinuojia, Guyoudao, etc., and has several product candidates under development, such as JY54, JY23, JY47, JY56, JY29-2, etc., targeting various indications. Geographically, the company generates maximum revenue from the Chinese Mainland, and the rest from other countries.
20GF Score
Get the complete analysis for HKSE:02566
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02566 has been successfully added to your 
